Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022

17-10-2021 | SARS-CoV-2 | Brief Communication

Yogic Neti-Kriya Using Povidone Iodine: Can it have a Preventive Role Against SARS-CoV-2 Infection Gateway?

Authors: Phulen Sarma, Anusuya Bhattacharyya, Ajay Prakash, Hardeep Kaur, Manisha Prajapat, Mukundam Borah, Subodh Kumar, Seema Bansal, Saurabh Sharma, Gurjeet Kaur, Harish Kumar, Dibya Jyoti Sharma, Karuna Kumar Das, Pramod Avti, Bikash Medhi

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Special Issue 2/2022

Login to get access

Abstract

During this COVID-19 pandemic, except steroid, none of the therapeutic measures have showed any evidence of efficacy. Traditionally jala-neti using lukewarm salted water remains a yogic way of maintaining upper airway hygiene. Saline irrigation decreases the concentration of inflammatory mediators (e.g. histamine, leukotriene etc.) in nasal secretions, reduces the severity and frequency of sinusitis, reduce need of antibiotic therapy and restores competency of nasal mucosa. Jala-neti is an integral part of six cleansing techniques of yogic kriyas practised in India since thousands of years. Jala-neti can clean the upper airways, prevents colonization of infectious agents, removes foreign bodies, prevents stasis of mucous and subsequently enhances the drainage of paranasal sinuses and maintain health. Regular practice of Jala neti improves nasal symptoms and overall health status of patients with sinusitis. Jala-neti sample can even be used for COVID-19 diagnosis. Povidone iodine (PVP-I) has been utilized as a time tested antimicrobial agent with broad spectrum coverage against wide range of bacteria and viruses. Anti-SARS-CoV-2 action of PVP-I was seen at a concentration as low as 0.45%. PVP-I is generally well tolerated upto 5%, however nasal ciliotoxicity is reported at this concentration, however, this toxicity is not reported with lower concentrations(1.25% and 0.5%). So, theoretically, by using neti-kriya with povidone iodine (0.5–1%) as irrigation solution can combine and enhance the protection against COVID-19 and this can be an important armor in the fight against COVID-19. However, this hypothesis needs to be validated in real life clinical trial scenario before implementing.
Literature
1.
go back to reference Bhattacharyya A, Kumar S, Sarma P, Kaur H, Prajapat M, Shekhar N et al (2020) Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol 52:313–323PubMedPubMedCentral Bhattacharyya A, Kumar S, Sarma P, Kaur H, Prajapat M, Shekhar N et al (2020) Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol 52:313–323PubMedPubMedCentral
2.
go back to reference Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A et al (2020) Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol 92:776–785PubMedPubMedCentralCrossRef Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A et al (2020) Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol 92:776–785PubMedPubMedCentralCrossRef
3.
go back to reference Prakash A, Singh H, Kaur H, Semwal A, Sarma P, Bhattacharyya A et al (2020) Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients. Indian J Pharmacol 52:414–421PubMedPubMedCentralCrossRef Prakash A, Singh H, Kaur H, Semwal A, Sarma P, Bhattacharyya A et al (2020) Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients. Indian J Pharmacol 52:414–421PubMedPubMedCentralCrossRef
4.
go back to reference Kaur H, Shekhar N, Sharma S, Sarma P, Prakash A, Medhi B (2021) Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep 73(3):736–749PubMedPubMedCentralCrossRef Kaur H, Shekhar N, Sharma S, Sarma P, Prakash A, Medhi B (2021) Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep 73(3):736–749PubMedPubMedCentralCrossRef
5.
go back to reference Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, Medhi B (2020) Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Indian J Pharmacol 52:1–5PubMedPubMedCentralCrossRef Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, Medhi B (2020) Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Indian J Pharmacol 52:1–5PubMedPubMedCentralCrossRef
6.
go back to reference Sarma P, Bhattacharyya A, Kaur H, Prajapat M, Prakash A, Kumar S et al (2020) Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol 52:535–550PubMedCrossRef Sarma P, Bhattacharyya A, Kaur H, Prajapat M, Prakash A, Kumar S et al (2020) Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol 52:535–550PubMedCrossRef
7.
go back to reference Bhattacharyya A, Sarma P, Kaur H, Medhi B (2021) Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med 174:434PubMedCrossRef Bhattacharyya A, Sarma P, Kaur H, Medhi B (2021) Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med 174:434PubMedCrossRef
8.
go back to reference Kaur H, Sarma P, Bhattacharyya A, Prajapat M, Kumar S, Prakash A et al (2021) Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses 149:110539PubMedPubMedCentralCrossRef Kaur H, Sarma P, Bhattacharyya A, Prajapat M, Kumar S, Prakash A et al (2021) Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses 149:110539PubMedPubMedCentralCrossRef
9.
go back to reference Prajapat M, Shekhar N, Sarma P, Avti P, Singh S, Kaur H et al (2020) Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model 101:107716PubMedPubMedCentralCrossRef Prajapat M, Shekhar N, Sarma P, Avti P, Singh S, Kaur H et al (2020) Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model 101:107716PubMedPubMedCentralCrossRef
10.
go back to reference Prajapat M, Sarma P, Shekhar N, Prakash A, Avti P, Bhattacharyya A et al (2020) Update on the target structures of SARS-CoV-2: A systematic review. Indian J Pharmacol 52:142–149PubMedPubMedCentralCrossRef Prajapat M, Sarma P, Shekhar N, Prakash A, Avti P, Bhattacharyya A et al (2020) Update on the target structures of SARS-CoV-2: A systematic review. Indian J Pharmacol 52:142–149PubMedPubMedCentralCrossRef
11.
12.
go back to reference Mahendiratta S, Batra G, Sarma P, Kumar H, Bansal S, Kumar S et al (2020) Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci 258:118207PubMedPubMedCentralCrossRef Mahendiratta S, Batra G, Sarma P, Kumar H, Bansal S, Kumar S et al (2020) Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci 258:118207PubMedPubMedCentralCrossRef
13.
go back to reference Kumar S, Sarma P, Kaur H, Prajapat M, Bhattacharyya A, Avti P et al (2021) Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell 70:101497PubMedPubMedCentralCrossRef Kumar S, Sarma P, Kaur H, Prajapat M, Bhattacharyya A, Avti P et al (2021) Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell 70:101497PubMedPubMedCentralCrossRef
14.
go back to reference Hazarika M, Das B, Das S, Baruah A, Sharma N, Barua C et al (2021) Profile of distress callers and service utilisation of tele-counselling among the population of Assam, India: an exploratory study during COVID-19. Open J Psychiatry Allied Sci 12:7–12PubMedPubMedCentralCrossRef Hazarika M, Das B, Das S, Baruah A, Sharma N, Barua C et al (2021) Profile of distress callers and service utilisation of tele-counselling among the population of Assam, India: an exploratory study during COVID-19. Open J Psychiatry Allied Sci 12:7–12PubMedPubMedCentralCrossRef
16.
go back to reference Meera S, Vandana Rani M, Sreedhar C, Robin DT (2020) A review on the therapeutic effects of NetiKriya with special reference to JalaNeti. J Ayurveda Integr Med 11:185–189PubMedCrossRef Meera S, Vandana Rani M, Sreedhar C, Robin DT (2020) A review on the therapeutic effects of NetiKriya with special reference to JalaNeti. J Ayurveda Integr Med 11:185–189PubMedCrossRef
17.
go back to reference Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM et al (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet Lond Engl 361:1767–1772CrossRef Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM et al (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet Lond Engl 361:1767–1772CrossRef
18.
go back to reference Sarma P, Kaur H, Medhi B, Bhattacharyya A (2020) Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 258(11):2575–2578CrossRef Sarma P, Kaur H, Medhi B, Bhattacharyya A (2020) Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 258(11):2575–2578CrossRef
19.
go back to reference Sarma P, Kaur H, Medhi B, Bhattacharyya A (2020) Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 258(11):2563–2565CrossRef Sarma P, Kaur H, Medhi B, Bhattacharyya A (2020) Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 258(11):2563–2565CrossRef
20.
go back to reference Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jenkins TM et al (2020) Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infect Dis Ther 9:669–675PubMedPubMedCentralCrossRef Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jenkins TM et al (2020) Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infect Dis Ther 9:669–675PubMedPubMedCentralCrossRef
21.
go back to reference Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B (2020) Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses. J Prosthodont Off J Am Coll Prosthodont 29:599–603CrossRef Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B (2020) Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses. J Prosthodont Off J Am Coll Prosthodont 29:599–603CrossRef
22.
go back to reference Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B (2020) Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse. J Prosthodont Off J Am Coll Prosthodont 29:529–533CrossRef Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B (2020) Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse. J Prosthodont Off J Am Coll Prosthodont 29:529–533CrossRef
23.
go back to reference Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ (2020) Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep 69:411–415PubMedPubMedCentralCrossRef Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ (2020) Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep 69:411–415PubMedPubMedCentralCrossRef
25.
go back to reference Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637PubMedPubMedCentralCrossRef Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637PubMedPubMedCentralCrossRef
26.
go back to reference Wu C, Zheng M. Single-Cell RNA Expression Profiling Shows that ACE2, the Putative Receptor of Wuhan 2019-nCoV, Has Significant Expression in the Nasal, Mouth, Lung and Colon Tissues, and Tends to be Co-Expressed with HLA-DRB1 in the Four Tissues. Preprints; 2020. Available from: https://www.preprints.org/manuscript/202002.0247/v1, accessed on March 29, 2020. Wu C, Zheng M. Single-Cell RNA Expression Profiling Shows that ACE2, the Putative Receptor of Wuhan 2019-nCoV, Has Significant Expression in the Nasal, Mouth, Lung and Colon Tissues, and Tends to be Co-Expressed with HLA-DRB1 in the Four Tissues. Preprints; 2020. Available from: https://​www.​preprints.​org/​manuscript/​202002.​0247/​v1, accessed on March 29, 2020.
27.
go back to reference Single-cell RNA expression profiling shows that ACE2, the putative receptor of COVID-2019, has significant expression in nasal and mouth tissue, and is co-expressed with TMPRSS2 and not co-expressed with SLC6A19 in the tissues. 2020. Available from: https://www.researchsquare.com/article/rs-16992/v1, accessed on March 29, 2020. Single-cell RNA expression profiling shows that ACE2, the putative receptor of COVID-2019, has significant expression in nasal and mouth tissue, and is co-expressed with TMPRSS2 and not co-expressed with SLC6A19 in the tissues. 2020. Available from: https://​www.​researchsquare.​com/​article/​rs-16992/​v1, accessed on March 29, 2020.
28.
go back to reference Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z et al (2020) SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med Massachusetts Medical Soc 382:1177–1179CrossRef Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z et al (2020) SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med Massachusetts Medical Soc 382:1177–1179CrossRef
29.
go back to reference Khan MM, Parab SR, Paranjape M (2020) Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol 41:102618PubMedPubMedCentralCrossRef Khan MM, Parab SR, Paranjape M (2020) Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol 41:102618PubMedPubMedCentralCrossRef
30.
go back to reference Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, Bhattacharjee PS et al (2011) Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci 52:339–344PubMedPubMedCentralCrossRef Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, Bhattacharjee PS et al (2011) Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci 52:339–344PubMedPubMedCentralCrossRef
31.
go back to reference Pinto RDP, Lira RPC, Abe RY, Zacchia RS, Felix JPF, Pereira AVF et al (2015) Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial. Curr Eye Res 40:870–877PubMedCrossRef Pinto RDP, Lira RPC, Abe RY, Zacchia RS, Felix JPF, Pereira AVF et al (2015) Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial. Curr Eye Res 40:870–877PubMedCrossRef
32.
go back to reference Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H et al (2017) Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol (Copenh) 95:686–692CrossRef Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H et al (2017) Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol (Copenh) 95:686–692CrossRef
33.
go back to reference Pepose JS, Narvekar A, Liu W, Haque R (2019) A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol Auckl NZ 13:535–544CrossRef Pepose JS, Narvekar A, Liu W, Haque R (2019) A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol Auckl NZ 13:535–544CrossRef
34.
go back to reference Lee VS, Pottinger PS, Davis GE (2020) Tolerability and effectiveness of povidone-iodine or mupirocin versus saline sinus irrigations for chronic rhinosinusitis. Am J Otolaryngol 41:102604PubMedPubMedCentralCrossRef Lee VS, Pottinger PS, Davis GE (2020) Tolerability and effectiveness of povidone-iodine or mupirocin versus saline sinus irrigations for chronic rhinosinusitis. Am J Otolaryngol 41:102604PubMedPubMedCentralCrossRef
35.
go back to reference Kariwa H, Fujii N, Takashima I (2006) Inactivation of SARS Coronavirus by Means of Povidone-Iodine, Physical Conditions and Chemical Reagents. Dermatol Basel Switz 212(Suppl 1):119–123CrossRef Kariwa H, Fujii N, Takashima I (2006) Inactivation of SARS Coronavirus by Means of Povidone-Iodine, Physical Conditions and Chemical Reagents. Dermatol Basel Switz 212(Suppl 1):119–123CrossRef
36.
go back to reference Eggers M, Koburger-Janssen T, Eickmann M, Zorn J (2018) In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther 7:249–259PubMedPubMedCentralCrossRef Eggers M, Koburger-Janssen T, Eickmann M, Zorn J (2018) In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther 7:249–259PubMedPubMedCentralCrossRef
37.
go back to reference Eggers M, Eickmann M, Zorn J (2015) Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA). Infect Dis Ther 4:491–501PubMedPubMedCentralCrossRef Eggers M, Eickmann M, Zorn J (2015) Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA). Infect Dis Ther 4:491–501PubMedPubMedCentralCrossRef
38.
go back to reference Kampf G, Todt D, Pfaender S, Steinmann E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect Elsevier 104:246–251CrossRef Kampf G, Todt D, Pfaender S, Steinmann E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect Elsevier 104:246–251CrossRef
39.
go back to reference Liang B, Yuan X, Wei G, Wang W, Zhang M, Peng H, et al. In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations. Microbiology; 2020 May. Available from: http://biorxiv.org/lookup/doi/https://doi.org/10.1101/2020.05.18.103184, accessed on May 22, 2021. Liang B, Yuan X, Wei G, Wang W, Zhang M, Peng H, et al. In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations. Microbiology; 2020 May. Available from: http://​biorxiv.​org/​lookup/​doi/​https://​doi.​org/​10.​1101/​2020.​05.​18.​103184, accessed on May 22, 2021.
40.
go back to reference Zoltán K. In Vitro Efficacy of “Essential Iodine Drops” Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). Pharmacology and Toxicology; 2020 Nov. Available from: http://biorxiv.org/lookup/doi/https://doi.org/10.1101/2020.11.07.370726, accessed on May 22, 2021. Zoltán K. In Vitro Efficacy of “Essential Iodine Drops” Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). Pharmacology and Toxicology; 2020 Nov. Available from: http://​biorxiv.​org/​lookup/​doi/​https://​doi.​org/​10.​1101/​2020.​11.​07.​370726, accessed on May 22, 2021.
41.
go back to reference Reimer K, Wichelhaus TA, Schäfer V, Rudolph P, Kramer A, Wutzler P et al (2002) Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatol Basel Switz 204(Suppl 1):114–120CrossRef Reimer K, Wichelhaus TA, Schäfer V, Rudolph P, Kramer A, Wutzler P et al (2002) Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatol Basel Switz 204(Suppl 1):114–120CrossRef
42.
go back to reference Patra SK (2017) Physiological effect of kriyas: Cleansing techniques. Int J Yoga - Philosop Psychol Parapsychol 5:3–5CrossRef Patra SK (2017) Physiological effect of kriyas: Cleansing techniques. Int J Yoga - Philosop Psychol Parapsychol 5:3–5CrossRef
43.
go back to reference Vollbehr NK, Bartels-Velthuis AA, Nauta MH, Castelein S, Steenhuis LA, Hoenders HJR et al (2018) Hatha yoga for acute, chronic and/or treatment-resistant mood and anxiety disorders: A systematic review and meta-analysis. PloS One 13:e0204925PubMedPubMedCentralCrossRef Vollbehr NK, Bartels-Velthuis AA, Nauta MH, Castelein S, Steenhuis LA, Hoenders HJR et al (2018) Hatha yoga for acute, chronic and/or treatment-resistant mood and anxiety disorders: A systematic review and meta-analysis. PloS One 13:e0204925PubMedPubMedCentralCrossRef
44.
go back to reference R. Bahadur, S. Chandra Vasu The gheranda samhita. The training of the physical body: chapter 1, verse 51 (1st ed.), Chaukhamba Sanskrit Pratishthan, Varanasi (2003), p. 18. R. Bahadur, S. Chandra Vasu The gheranda samhita. The training of the physical body: chapter 1, verse 51 (1st ed.), Chaukhamba Sanskrit Pratishthan, Varanasi (2003), p. 18.
45.
go back to reference Tomooka LT, Murphy C, Davidson TM (2000) Clinical study and literature review of nasal irrigation. Laryngoscope 110:1189–1193PubMedCrossRef Tomooka LT, Murphy C, Davidson TM (2000) Clinical study and literature review of nasal irrigation. Laryngoscope 110:1189–1193PubMedCrossRef
46.
go back to reference Shoseyov D, Bibi H, Shai P, Shoseyov N, Shazberg G, Hurvitz H (1998) Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol 101:602–605PubMedCrossRef Shoseyov D, Bibi H, Shai P, Shoseyov N, Shazberg G, Hurvitz H (1998) Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol 101:602–605PubMedCrossRef
47.
go back to reference Lin SY, Baugher KM, Brown DJ, Ishman SL (2015) Effects of nasal saline lavage on pediatric sinusitis symptoms and disease-specific quality of life: a case series of 10 patients. Ear Nose Throat J 94:E13-18PubMedCrossRef Lin SY, Baugher KM, Brown DJ, Ishman SL (2015) Effects of nasal saline lavage on pediatric sinusitis symptoms and disease-specific quality of life: a case series of 10 patients. Ear Nose Throat J 94:E13-18PubMedCrossRef
48.
go back to reference Georgitis JW (1994) Nasal hyperthermia and simple irrigation for perennial rhinitis. Changes in inflammatory mediators Chest 106:1487–1492PubMed Georgitis JW (1994) Nasal hyperthermia and simple irrigation for perennial rhinitis. Changes in inflammatory mediators Chest 106:1487–1492PubMed
50.
go back to reference Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R (2002) Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract 51:1049–1055PubMed Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R (2002) Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract 51:1049–1055PubMed
51.
go back to reference Tano L, Tano K (2004) A daily nasal spray with saline prevents symptoms of rhinitis. Acta Otolaryngol (Stockh) 124:1059–1062PubMedCrossRef Tano L, Tano K (2004) A daily nasal spray with saline prevents symptoms of rhinitis. Acta Otolaryngol (Stockh) 124:1059–1062PubMedCrossRef
52.
go back to reference Kumara H, Minrupa B, Karunaratne S, Karunaratne H. Yoga Therapy for Immunomodulation (Prevent & Cure) of COVID-19. 2021. Kumara H, Minrupa B, Karunaratne S, Karunaratne H. Yoga Therapy for Immunomodulation (Prevent & Cure) of COVID-19. 2021.
54.
go back to reference Achilles N, Mösges R (2013) Nasal Saline Irrigations for the Symptoms of Acute and Chronic Rhinosinusitis. Curr Allergy Asthma Rep 13:229–235PubMedCrossRef Achilles N, Mösges R (2013) Nasal Saline Irrigations for the Symptoms of Acute and Chronic Rhinosinusitis. Curr Allergy Asthma Rep 13:229–235PubMedCrossRef
55.
go back to reference Gupta A, Gupta B (2020) Jal Neti Sample for COVID Detection: A Novel Hypothesis. Indian J Otolaryngol Head Neck Surg Off Publ Assoc Otolaryngol India 73(1):104–106CrossRef Gupta A, Gupta B (2020) Jal Neti Sample for COVID Detection: A Novel Hypothesis. Indian J Otolaryngol Head Neck Surg Off Publ Assoc Otolaryngol India 73(1):104–106CrossRef
58.
go back to reference Calame A, Mazza L, Renzoni A, Kaiser L, Schibler M (2021) Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage. Eur J Clin Microbiol Infect Dis 40:441–445PubMedCrossRef Calame A, Mazza L, Renzoni A, Kaiser L, Schibler M (2021) Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage. Eur J Clin Microbiol Infect Dis 40:441–445PubMedCrossRef
59.
go back to reference Chundamala J, Wright JG (2007) The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review. Can J Surg J Can Chir 50:473–481 Chundamala J, Wright JG (2007) The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review. Can J Surg J Can Chir 50:473–481
60.
go back to reference Phillips M, Rosenberg A, Shopsin B, Cuff G, Skeete F, Foti A et al (2014) Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol 35:826–832PubMedPubMedCentralCrossRef Phillips M, Rosenberg A, Shopsin B, Cuff G, Skeete F, Foti A et al (2014) Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol 35:826–832PubMedPubMedCentralCrossRef
61.
go back to reference Kim JH, Rimmer J, Mrad N, Ahmadzada S, Harvey RJ (2015) Betadine has a ciliotoxic effect on ciliated human respiratory cells. J Laryngol Otol Cambridge University Press 129:S45-50CrossRef Kim JH, Rimmer J, Mrad N, Ahmadzada S, Harvey RJ (2015) Betadine has a ciliotoxic effect on ciliated human respiratory cells. J Laryngol Otol Cambridge University Press 129:S45-50CrossRef
62.
go back to reference Ramezanpour M, Smith JLP, Psaltis AJ, Wormald PJ, Vreugde S (2020) In vitro safety evaluation of a povidone-iodine solution applied to human nasal epithelial cells. Int Forum Allergy Rhinol 10:1141–1148PubMedCrossRef Ramezanpour M, Smith JLP, Psaltis AJ, Wormald PJ, Vreugde S (2020) In vitro safety evaluation of a povidone-iodine solution applied to human nasal epithelial cells. Int Forum Allergy Rhinol 10:1141–1148PubMedCrossRef
63.
go back to reference Kramer A, Below H, Behrens-Baumann W, Müller G, Rudolph P, Reimer K (2002) New aspects of the tolerance of the antiseptic povidone-iodine in different ex vivo models. Dermatol Basel Switz 204(Suppl 1):86–91CrossRef Kramer A, Below H, Behrens-Baumann W, Müller G, Rudolph P, Reimer K (2002) New aspects of the tolerance of the antiseptic povidone-iodine in different ex vivo models. Dermatol Basel Switz 204(Suppl 1):86–91CrossRef
64.
go back to reference Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR (2020) Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol 105:104724PubMedPubMedCentralCrossRef Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR (2020) Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral Oncol 105:104724PubMedPubMedCentralCrossRef
Metadata
Title
Yogic Neti-Kriya Using Povidone Iodine: Can it have a Preventive Role Against SARS-CoV-2 Infection Gateway?
Authors
Phulen Sarma
Anusuya Bhattacharyya
Ajay Prakash
Hardeep Kaur
Manisha Prajapat
Mukundam Borah
Subodh Kumar
Seema Bansal
Saurabh Sharma
Gurjeet Kaur
Harish Kumar
Dibya Jyoti Sharma
Karuna Kumar Das
Pramod Avti
Bikash Medhi
Publication date
17-10-2021
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue Special Issue 2/2022
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-021-02885-2

Other articles of this Special Issue 2/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022 Go to the issue